# Omega-6/Omega-3 Ratio as a Protective Factor in Lung Cancer: A Mendelian Randomization Study on Polyunsaturated Fatty Acids and Lung Adenocarcinoma Risk

**Authors:** Cheng Wang, Ya Ding, Qikang Hu, Bin Wang, Shouzhi Xie, Zhi Yang, Zhe Zhang, Dexing Dai, An Xiong, Ruoman Sun, Yali Ling, Lei Qiu, Fenglei Yu, Zhongjian Xie, Muyun Peng

PMC · DOI: 10.7150/jca.112416 · Journal of Cancer · 2025-06-12

## TL;DR

This study finds that a higher ratio of omega-6 to omega-3 fatty acids may protect against lung cancer, especially lung adenocarcinoma.

## Contribution

The study provides causal evidence that the omega-6/omega-3 ratio, rather than individual fatty acids, reduces lung cancer risk.

## Key findings

- A higher omega-6/omega-3 ratio is associated with reduced lung cancer and lung adenocarcinoma risk.
- Elevated omega-3 and DHA levels are linked to increased lung adenocarcinoma risk.
- The protective effect remains after adjusting for BMI, smoking, and genetic pleiotropy.

## Abstract

Background: While observational studies have reported conflicting associations between polyunsaturated fatty acids (PUFAs) and lung cancer risk, the causal role of specific PUFA subtypes remains unclear.

Methods: Leveraging genome-wide association data from the UK Biobank and International Lung Cancer Consortium, we employed univariable, multivariable, and bidirectional Mendelian randomization (MR) analyses to investigate the causal effects of seven PUFA traits (including omega-3, DHA, EPA, omega-6, LA, AA, and the omega-6/omega-3 ratio) on lung cancer and its subtypes.

Results: Our primary finding revealed a robust protective effect of a higher omega-6/omega-3 ratio against overall lung cancer (IVW: OR = 0.87; 95% CI: 0.78-0.96; P_value = 0.009) and lung adenocarcinoma (LUAD) (IVW: OR = 0.78; 95% CI: 0.67-0.89; P_value = 0.0005). Conversely, elevated omega-3 and DHA levels were associated with increased LUAD risk. These associations persisted after adjusting for BMI, smoking, and potential pleiotropy.

Conclusion: This study provides the first causal evidence that a higher omega-6/omega-3 ratio reduces lung cancer risk, particularly LUAD, through multivariable and bidirectional Mendelian randomization analyses that account for BMI, smoking, and genetic pleiotropy. These findings highlight the ratio's potential as a novel and modifiable dietary target for prevention, offering actionable insights beyond prior studies focused on individual PUFA subtypes.

## Linked entities

- **Chemicals:** omega-3 (PubChem CID 1548943), DHA (PubChem CID 15608515), EPA (PubChem CID 446284), LA (PubChem CID 23926), AA (PubChem CID 139137014)
- **Diseases:** lung cancer (MONDO:0005138), lung adenocarcinoma (MONDO:0005061)

## Full-text entities

- **Diseases:** Lung Cancer (MESH:D008175), LUAD (MESH:D000077192)
- **Chemicals:** LA (MESH:D007811), DHA (MESH:C027493), AA (-), PUFA (MESH:D005231)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12170990/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12170990/full.md

## References

84 references — full list in the complete paper: https://tomesphere.com/paper/PMC12170990/full.md

---
Source: https://tomesphere.com/paper/PMC12170990